PHIO PHARMACEUTICALS CORP. Increase (Decrease) in Deferred Revenue
PHIO PHARMACEUTICALS CORP. (PHIO) reported Increase (Decrease) in Deferred Revenue of -$47.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-03-30
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for the quarter ending 2015-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for the quarter ending 2015-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for the quarter ending 2015-03-31 was -$47.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for fiscal 2015 was -$47.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for fiscal 2014 was -$71.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for fiscal 2013 was -$400.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in deferred revenue for fiscal 2012 was -$298.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 111 month | Increase (Decrease) in Deferred Revenue 114 month | Increase (Decrease) in Deferred Revenue 117 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $0.00 derived: sum of 3 quarters · filed 2017-03-30 | -$47.00K 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | -$47.00K 10-Q · filed 2016-11-10 | -$61.00K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$47.00K 10-Q · filed 2016-08-11 | -$61.00K derived: sum of 3 quarters · filed 2016-08-11 | -$78.00K derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | -$47.00K 10-Q · filed 2016-05-12 | -$61.00K derived: sum of 2 quarters · filed 2016-05-12 | -$78.00K derived: sum of 3 quarters · filed 2016-05-12 | -$89.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$31.00K derived: sum of 2 quarters · filed 2016-03-30 | -$42.00K derived: sum of 3 quarters · filed 2016-03-30 | -$71.00K 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$28.00K derived: sum of 2 quarters · filed 2015-11-12 | -$57.00K 10-Q · filed 2015-11-12 | -$86.00K derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$40.00K 10-Q · filed 2015-08-12 | -$69.00K derived: sum of 3 quarters · filed 2015-08-12 | -$161.00K derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | -$29.00K 10-Q · filed 2015-05-13 | -$58.00K derived: sum of 2 quarters · filed 2015-05-13 | -$150.00K derived: sum of 3 quarters · filed 2015-05-13 | -$788.00K derived: sum of 4 quarters · filed 2015-05-13 | ||||
| 2013-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$121.00K derived: sum of 2 quarters · filed 2015-03-30 | -$759.00K derived: sum of 3 quarters · filed 2015-03-30 | -$400.00K 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | -$92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$730.00K derived: sum of 2 quarters · filed 2014-11-13 | -$371.00K 10-Q · filed 2014-11-13 | -$522.00K derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | -$638.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$279.00K 10-Q · filed 2014-08-14 | -$430.00K derived: sum of 3 quarters · filed 2014-08-14 | -$528.00K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $359.00K 10-Q · filed 2014-05-14 | -$54.00K 10-Q · filed 2013-05-15 | $208.00K derived: sum of 2 quarters · filed 2014-05-14 | $110.00K derived: sum of 3 quarters · filed 2014-05-14 | $80.00K derived: sum of 4 quarters · filed 2014-05-14 | |||
| 2012-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$249.00K derived: sum of 2 quarters · filed 2014-03-28 | -$279.00K derived: sum of 3 quarters · filed 2014-03-28 | -$298.00K 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | -$98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$128.00K derived: sum of 2 quarters · filed 2013-11-14 | -$147.00K 10-Q · filed 2013-11-14 | $669.00K 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$49.00K 10-Q · filed 2013-08-14 | $767.00K 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | -$19.00K 10-Q · filed 2013-05-15 | $797.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |